Logo image of RR

RICHTECH ROBOTICS INC-CL B (RR) Stock Fundamental Analysis

NASDAQ:RR - Nasdaq - US7655041058 - Common Stock - Currency: USD

1.99  -0.02 (-1%)

After market: 1.98 -0.01 (-0.5%)

Fundamental Rating

3

RR gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 127 industry peers in the Machinery industry. RR has a great financial health rating, but its profitability evaluates not so good. RR is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

RR had negative earnings in the past year.
In the past year RR has reported a negative cash flow from operations.
RR Yearly Net Income VS EBIT VS OCF VS FCFRR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 -2M -4M -6M -8M -10M

1.2 Ratios

The Return On Assets of RR (-21.62%) is worse than 85.04% of its industry peers.
RR's Return On Equity of -22.11% is on the low side compared to the rest of the industry. RR is outperformed by 78.74% of its industry peers.
Industry RankSector Rank
ROA -21.62%
ROE -22.11%
ROIC N/A
ROA(3y)-12.12%
ROA(5y)N/A
ROE(3y)-14.3%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
RR Yearly ROA, ROE, ROICRR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 -50 -100 -150 -200 -250

1.3 Margins

With an excellent Gross Margin value of 74.61%, RR belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
In the last couple of years the Gross Margin of RR has grown nicely.
RR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 74.61%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.85%
GM growth 5YN/A
RR Yearly Profit, Operating, Gross MarginsRR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 50 -50 -100 -150

More info and screens

8

2. Health

2.1 Basic Checks

RR does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for RR has been increased compared to 1 year ago.
The debt/assets ratio for RR has been reduced compared to a year ago.
RR Yearly Shares OutstandingRR Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 20M 40M 60M 80M
RR Yearly Total Debt VS Total AssetsRR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

An Altman-Z score of 107.88 indicates that RR is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 107.88, RR belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
There is no outstanding debt for RR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 107.88
ROIC/WACCN/A
WACC9.92%
RR Yearly LT Debt VS Equity VS FCFRR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 10M -10M 20M 30M 40M

2.3 Liquidity

A Current Ratio of 75.74 indicates that RR has no problem at all paying its short term obligations.
With an excellent Current ratio value of 75.74, RR belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
A Quick Ratio of 73.23 indicates that RR has no problem at all paying its short term obligations.
RR has a Quick ratio of 73.23. This is amongst the best in the industry. RR outperforms 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 75.74
Quick Ratio 73.23
RR Yearly Current Assets VS Current LiabilitesRR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 10M 20M 30M

More info and screens

4

3. Growth

3.1 Past

RR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -301.40%.
Looking at the last year, RR shows a very negative growth in Revenue. The Revenue has decreased by -51.07% in the last year.
The Revenue for RR have been decreasing by -11.08% on average. This is quite bad
EPS 1Y (TTM)-301.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-138.1%
Revenue 1Y (TTM)-51.07%
Revenue growth 3Y-11.08%
Revenue growth 5YN/A
Sales Q2Q%0.17%

3.2 Future

The Earnings Per Share is expected to grow by 11.35% on average over the next years. This is quite good.
RR is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 45.78% yearly.
EPS Next Y-38.63%
EPS Next 2Y-0.14%
EPS Next 3Y11.35%
EPS Next 5YN/A
Revenue Next Year36.86%
Revenue Next 2Y70.97%
Revenue Next 3Y70.14%
Revenue Next 5Y45.78%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
RR Yearly Revenue VS EstimatesRR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 10M 20M 30M
RR Yearly EPS VS EstimatesRR Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 -0.05 -0.1 -0.15

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

RR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year RR is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RR Price Earnings VS Forward Price EarningsRR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
RR Per share dataRR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-0.14%
EPS Next 3Y11.35%

More info and screens

0

5. Dividend

5.1 Amount

RR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

RICHTECH ROBOTICS INC-CL B

NASDAQ:RR (7/18/2025, 8:10:13 PM)

After market: 1.98 -0.01 (-0.5%)

1.99

-0.02 (-1%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners11.37%
Inst Owner Change0%
Ins Owners1.69%
Ins Owner Change-5.45%
Market Cap228.45M
Analysts83.64
Price Target3.2 (60.8%)
Short Float %27.01%
Short Ratio1.86
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-3.59%
PT rev (3m)N/A
EPS NQ rev (1m)-33.33%
EPS NQ rev (3m)N/A
EPS NY rev (1m)-25.34%
EPS NY rev (3m)-4.45%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.46%
Revenue NY rev (3m)-3.43%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 52.02
P/FCF N/A
P/OCF N/A
P/B 4.09
P/tB 4.91
EV/EBITDA N/A
EPS(TTM)-0.14
EYN/A
EPS(NY)-0.12
Fwd EYN/A
FCF(TTM)-0.15
FCFYN/A
OCF(TTM)-0.09
OCFYN/A
SpS0.04
BVpS0.49
TBVpS0.41
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -21.62%
ROE -22.11%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 74.61%
FCFM N/A
ROA(3y)-12.12%
ROA(5y)N/A
ROE(3y)-14.3%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.85%
GM growth 5YN/A
F-Score4
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 75.74
Quick Ratio 73.23
Altman-Z 107.88
F-Score4
WACC9.92%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-301.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-138.1%
EPS Next Y-38.63%
EPS Next 2Y-0.14%
EPS Next 3Y11.35%
EPS Next 5YN/A
Revenue 1Y (TTM)-51.07%
Revenue growth 3Y-11.08%
Revenue growth 5YN/A
Sales Q2Q%0.17%
Revenue Next Year36.86%
Revenue Next 2Y70.97%
Revenue Next 3Y70.14%
Revenue Next 5Y45.78%
EBIT growth 1Y-1126.06%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-116.24%
EBIT Next 3Y18.53%
EBIT Next 5YN/A
FCF growth 1Y-542.74%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-298.23%
OCF growth 3YN/A
OCF growth 5YN/A